Tranquilizers and antimanic and antianxiety drugs

BROMAZOLAM-13C6

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Buspirone-d8 Hydrochloride is a non-benzodiazepine anxiolytic SR (5-hydroxytryptamine,5-HT1) receptor agonist.

A potent and selective inhibitor of CK2 with an IC50 value of 0.3 &microM and a Ki value of 0.2 &microM.

Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .

Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .

Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .

Centhaquine (Centhaquin: PMZ-2010) is a novel agent has the potential for treatment of? haemorrhagic shock . Centhaquine (Centhaquin: PMZ-2010) can augment cardiac output, reduce?systemic vascular resistance in haemorrhagic models .

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the